Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE:000623)
China
· Delayed Price · Currency is CNY 18.36
-0.35 (-1.87%)
Mar 9, 2026, 3:04 PM CST
SHE:000623 Revenue
Jilin Aodong Pharmaceutical Group had revenue of 513.94M CNY in the quarter ending September 30, 2025, with 3.25% growth. This brings the company's revenue in the last twelve months to 2.34B, down -22.08% year-over-year. In the year 2024, Jilin Aodong Pharmaceutical Group had annual revenue of 2.61B, down -24.31%.
Revenue (ttm)
2.34B
Revenue Growth
-22.08%
P/S Ratio
9.19
Revenue / Employee
407.55K
Employees
5,454
Market Cap
21.52B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.61B | -838.55M | -24.31% |
| Dec 31, 2023 | 3.45B | 580.91M | 20.25% |
| Jan 1, 2023 | 2.87B | 564.45M | 24.50% |
| Jan 1, 2022 | 2.30B | 52.11M | 2.31% |
| Dec 31, 2020 | 2.25B | -836.73M | -27.09% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Tasly Pharmaceutical Group | 8.24B |
| Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd | 1.25B |
| Joincare Pharmaceutical Group Industry | 15.20B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 6.02B |
| Dizal (Jiangsu) Pharmaceutical | 801.14M |
| Apeloa Pharmaceutical Co.,Ltd | 10.50B |
| Zhejiang Huahai Pharmaceutical | 8.71B |
| Wedge Industrial | 1.24B |